Peptides & the Unregulated Fringe
Where real caution is warranted
This section covers the tier of the longevity space with the least evidence and the most risk.
What's Being Discussed
Synthetic peptides such as BPC-157 and TB-500 are widely discussed in longevity and performance communities for claimed tissue repair, gut healing, and anti-inflammatory effects. The evidence position: these compounds are largely unregulated, sold outside standard pharmaceutical oversight in most jurisdictions, and lack the kind of robust, controlled human trial data that essentially everything else in this guide, even the more speculative Tier 3 interventions, has at least some of.
Why This Is a Different Risk Category
The interventions covered in Sections 6 and 7 — while their longevity-specific benefit remains unproven — are at least well-characterised, approved compounds with known safety profiles from decades of use for their original indications. Peptides in this unregulated category typically lack that safety history entirely for the population using them, meaning real unknowns exist not just about efficacy but about basic safety, purity, and dosing. General guidance on evaluating unregulated compounds and off-label use with a physician is covered in the Medication Literacy guide; dosing and product-quality considerations for the supplement-adjacent end of this space are covered in the Supplements guide.
The bottom line
If you're considering a compound in this category, that decision should involve a physician, not an online forum — the absence of robust human trial data cuts both ways: it means the claimed benefits aren't well established, and it also means the safety profile isn't well established either.